Cash & equivalents decreased 86.2%
Cash & equivalents changed -86.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$4.1M→$566,0004 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →SCLX financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Trade receivables decreased 61.6%
Trade receivables changed -61.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$16.8M→$6.4M4 prior comparisons
Operating cash flow changed across a sign change
Operating cash flow changed -195.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
$7.1M→-$6.7M4 prior comparisons
Inventory increased 65.6%
Inventory changed +65.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$2.5M→$4.2M4 prior comparisons
Operating income decreased 43.5%
Operating income changed -43.5% from the comparable as-filed period.
-$20.5M→-$29.4M3 prior comparisons
Gross margin moved 13982 bp higher
Gross margin changed +13982 basis points from the comparable as-filed period.
66.94%→206.75%3 prior comparisons
Operating margin moved 17779 bp lower
Operating margin changed -17779 basis points from the comparable as-filed period.
-207.23%→-385.02%3 prior comparisons
Working capital / assets moved 13734 bp higher
Working capital / assets changed +13734 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
-325.07%→-187.73%4 prior comparisons
Current ratio decreased 35.7%
Current ratio changed -35.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
0.11→0.074 prior comparisons
Research & development decreased 46.1%
Research & development changed -46.1% from the comparable as-filed period.
$6.2M→$3.3M3 prior comparisons
Working capital decreased 74.8%
Working capital changed -74.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
-$272.3M→-$476.0M4 prior comparisons
Current liabilities increased 67.4%
Current liabilities changed +67.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$305.9M→$512.2M4 prior comparisons
Total assets increased 202.7%
Total assets changed +202.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$83.8M→$253.6M4 prior comparisons
Revenue decreased 22.8%
Revenue changed -22.8% from the comparable as-filed period.
$9.9M→$7.6M3 prior comparisons
Selling, general & administrative increased 40.9%
Selling, general & administrative changed +40.9% from the comparable as-filed period.
$19.8M→$28.0M3 prior comparisons
Inventory / revenue moved 2913 bp higher
Inventory / revenue changed +2913 basis points from the comparable as-filed period.
25.45%→54.58%3 prior comparisons
SBC / revenue moved 1391 bp higher
SBC / revenue changed +1391 basis points from the comparable as-filed period.
33.13%→47.04%3 prior comparisons
Shares outstanding increased 22.1%
Shares outstanding changed +22.1% from the comparable as-filed period. The change ranks at the 14th percentile of 7 prior comparable changes.
6,955,697→8,493,0007 prior comparisons
Operating cash-flow margin moved 15940 bp lower
Operating cash-flow margin changed -15940 basis points from the comparable as-filed period.
71.24%→-88.16%3 prior comparisons
Receivables / revenue moved 8517 bp lower
Receivables / revenue changed -8517 basis points from the comparable as-filed period.
169.43%→84.26%3 prior comparisons
R&D / revenue moved 1887 bp lower
R&D / revenue changed -1887 basis points from the comparable as-filed period.
62.52%→43.65%3 prior comparisons
Current assets increased 7.6%
Current assets changed +7.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$33.7M→$36.2M4 prior comparisons
Cost of revenue increased 12.4%
Cost of revenue changed +12.4% from the comparable as-filed period.
$3.3M→$3.7M3 prior comparisons
Stock-based compensation increased 9.6%
Stock-based compensation changed +9.6% from the comparable as-filed period.
$3.3M→$3.6M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.